Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_3916_Библиотеки_им_академика_М_И_Перельмана
.pdf
Index
197
graft technique, 129
grafts, 44, 45, 75, 83, 84, 115, 116, 120, 123, 125,
128, 131, 136, 137, 138, 182, 186, 187, 190, 191
grants, 72
gravity, 59, 183, 188
growth, vii, viii, 1, 3, 7, 10, 16, 18, 23, 26, 31, 32,
33, 40, 41, 42, 44, 45, 46, 47, 49, 50, 53, 55, 56,
61, 62, 63, 64, 71, 76, 77, 120, 148, 152, 153,
157, 161, 162, 163, 166, 170
growth factor, 3, 61, 71, 148, 153
growth rate, viii, 31, 32, 33, 41, 42, 44, 47, 50, 63,
77
guidance, 48, 120
guidelines, x, 27, 64, 75, 120, 129, 131, 145, 146,
147, 153
H
haplotypes, 9
healing, 114
health, 13, 22, 27, 120, 140, 142, 144, 145, 146, 147,
151
health care costs, 140, 145
health care professionals, 145
health care system, 142, 146, 147, 151
heart disease, 164
heart failure, 158, 165
heart rate, 183
height, 8
hemangioma, 85
hemodynamics, xi, xii, 46, 47, 78, 155, 157, 158,
159, 160, 161, 163, 166, 167, 181, 182, 186
hemorrhage, 2
hepatic fibrosis, 179
heterogeneity, 3, 9, 23, 114
high blood pressure, 59
histological examination, 78
histology, 164
histomorphometric, ix, 82, 110
history, 4, 5, 7, 8, 15, 17, 58, 59, 72, 84, 135, 142,
147, 182
HLA, 2, 20
homeostasis, 164
homocysteine, 13
hormone, 158
hospitalization, x, 119
human, vii, xi, 1, 2, 9, 17, 20, 24, 25, 47, 48, 49, 50,
52, 53, 55, 56, 62, 63, 64, 65, 70, 71, 72, 74, 75,
76, 77, 78, 79, 111, 115, 117, 132, 137, 152, 155,
157, 158, 160, 162, 164, 166
human genome, vii, 1
human leukocyte antigen, 2
hydronephrosis, 84, 85
hypercholesterolemia, 7, 8, 164
hyperlipidemia, 15
hyperplasia, 84, 85
hypertension, 7, 8, 22, 58, 73, 82, 147, 156
hypothesis, 18, 177
hypoxia, 40, 55, 59, 117
I
IBD, 9
ICAM, 159
Iceland, 15
ideal, x, 35, 119, 147
identification, 19, 52, 116
identity, 9
IL-17, 154
IL-8, 61
IMA, 126
image(s), xi, 34, 38, 53, 56, 67, 121, 131, 141, 142,
159, 160, 161, 163, 169, 170, 171, 172, 178, 179,
189
imaging modalities, 158, 161
imaging systems, 159
immersion, 87
immune function, 24
immune response, 61, 74, 76
immune system, 10
immunoglobulin, 34
immunohistochemistry, viii, 57, 66
improvements, 46, 120, 161
in vitro, 64
in vivo, xi, 32, 36, 37, 38, 41, 43, 44, 46, 47, 64, 65,
78, 79, 82, 155, 157, 159, 160, 161, 191
incidence, 6, 28, 55, 113, 116, 120, 126, 127, 131,
134, 140, 144, 150, 156, 158
individuals, 5, 8, 9, 13, 17, 18, 19, 148, 186
induction, 65, 70, 113, 114, 152, 158, 160
industrialized countries, 156
inertia, 172
infants, 20
infarction, 15
infection, 62, 76, 127
inflammation, viii, ix, 10, 12, 24, 52, 54, 57, 58, 60,
61, 65, 70, 71, 72, 76, 82, 86, 87, 95, 96, 97, 99,
101, 111, 112, 113, 114, 116, 148, 153, 154, 156
inflammatory cells, ix, 40, 58, 61, 63, 66, 67, 69, 71
inflammatory mediators, 61
inflammatory responses, 70
infusion model, 17
inheritance, 4, 7, 8, 9, 23
inhibition, 63, 64, 77, 153
inhibitor, vii, 1, 14, 23, 64, 76, 153, 154, 164, 165
initial state, 44
initiation, 44, 110
injure, 59
https://t.me/med1917
Index
198
injury(ies), viii, 17, 46, 57, 65, 71, 78, 133, 162
insertion, viii, 12, 31, 32
integrity, 27, 113, 120, 164
intensity values, 170
intensive care unit, 62
interface, 188
interference, 182, 190
interferon, 17, 27, 34
interleukin, vii, 1, 9, 12, 61
intervention, 33, 62, 126, 128, 135, 148
intima, 42, 58, 87
intracranial aneurysm, 8, 14, 15, 17, 23, 26, 27, 178
intron, 12, 15, 164
introns, 10
ionizing radiation, 121
Ireland, 5
isolation, 70
Israel, 181
issues, 133
Italy, 190
J
joints, 187
Jordan, 48, 50
K
kidney, 42
kidneys, 182, 186
kinase inhibitors, vii, 1
L
Lagrangian formulation, 43
lamella, 65
laminar, 71, 122, 183
language processing, 16
laparotomy, 120
lattices, 8
laws, 83
LDL, 15, 76, 157, 158, 159
lead, 3, 17, 18, 39, 45, 82, 96, 109, 120, 127, 156,
182, 186, 189
leakage, 178, 188, 189
leaks, xi, 45, 169, 170
learning, 173
lesions, 59, 60, 72, 74, 77, 83, 85, 164, 165
leukocytes, 10
lifetime, 29
ligand, 15
light, 87
lipid metabolism, 10, 11
lipids, 76
lipoprotein, vii, 1, 9, 14, 15, 26, 27, 34, 157, 164
liver, 84, 85, 179, 182, 186
liver disease, 84, 85
local anesthesia, 62
localization, 39, 74, 85, 166
loci, vii, 1, 9, 15
locus, 9, 15, 17, 18, 24
longitudinal study, 161
low-density lipoprotein, 26
lumen, 38, 39, 65, 66, 71, 122, 161, 183, 186, 188
lung cancer, 7
lymphocytes, viii, 57, 61
lymphoid, 87
lymphoma, 179
M
machine learning, 174, 179
macromolecules, 39
macrophages, viii, 57, 61, 64, 66, 67, 70, 74, 113
magnetic resonance imaging, 140, 163
magnitude, viii, 31, 41, 43, 46
majority, 61, 62, 126, 182
male animals, 158
man, 27
management, viii, xi, 2, 16, 18, 19, 21, 22, 24, 28,
31, 46, 55, 64, 72, 73, 75, 77, 78, 120, 126, 131,
133, 135, 137, 139, 148, 150, 152, 153, 170, 171,
182
manufacturing, 35
mapping, 23, 174
Marfan syndrome, 3, 20, 164
mass, 170, 190
mast cell stabilizer, 64
mast cells, 64, 75
materials, 65, 83
matrix, viii, xi, 23, 34, 60, 70, 77, 79, 115, 149, 169,
172
matrix metalloproteinase, viii, 7, 12, 22, 25, 26, 54,
57, 74, 75, 76, 78, 113, 148, 152, 153, 165
matter, 157
MCP, 61, 79
MCP-1, 61, 79
mean arterial pressure, 40
measurement(s), xi, 35, 36, 38, 43, 87, 121, 122,
140, 155, 157, 161, 170
mechanical properties, 39, 50, 55, 56, 115, 190
mechanical stress, 52, 82, 83, 113
media, ix, 8, 18, 40, 42, 44, 58, 60, 61, 65, 81, 82,
87, 90, 91, 92, 93, 94, 96, 97, 99, 101, 103, 104,
105, 107, 109, 111, 112, 113, 114
median, 15, 33, 172
medical, xi, 5, 16, 27, 58, 64, 75, 78, 83, 145, 146,
153, 155, 156, 170
medical care, 156
https://t.me/med1917
Index
199
Medicare, 142, 145, 150
medication, 63, 64
medicine, 16, 72, 131, 132, 179, 182, 190
meta-analysis, 11, 12, 13, 25, 76, 138, 148, 150, 152,
154
metabolism, 11, 13, 26, 52, 152
metalloproteinase, 34, 70, 74, 79, 149, 152, 164
methodology, xi, 43, 87, 155, 159, 160, 161, 171
mice, xi, 15, 17, 20, 22, 27, 63, 76, 77, 78, 153, 155,
157, 158, 159, 161, 164, 165, 166, 167
microscope, ix, 82, 87
microstructure, 55
migration, x, 45, 46, 51, 119, 120, 125, 127, 128,
131, 134, 136, 137, 189
military, 6
MMP, viii, 13, 57, 60, 61, 62, 63, 66, 69, 70, 77,
112, 148, 149, 153
MMP-2, viii, 57, 60, 62, 66, 69, 70
MMP-9, 60, 62, 63, 66, 69, 70, 77, 112, 148
MMPs, viii, 8, 12, 13, 16, 57, 60, 63, 70, 71
modelling, 47, 163
models, ix, xi, 8, 9, 23, 35, 37, 38, 40, 41, 43, 46, 50,
51, 52, 55, 62, 63, 64, 70, 71, 72, 74, 78, 79, 81,
82, 83, 110, 111, 112, 116, 117, 155, 157, 158,
162, 163, 183, 184, 185
modifications, 65, 75, 182, 186
modulus, 56
molecules, 17, 61
momentum, 173, 183
monocyte chemoattractant protein, 61
morbidity, x, 62, 119, 120
morphology, x, 58, 70, 120, 121, 122, 123, 128, 131
morphometric, vii, ix, 66, 68, 81, 82, 83, 87, 88, 91,
94, 95, 99, 101, 103, 105, 107, 109, 111, 113, 116
mortality, x, 2, 33, 46, 47, 50, 58, 59, 62, 73, 110,
119, 120, 129, 130, 139, 140, 141, 142, 143, 146,
149, 150, 151, 186, 189
mortality rate, 33, 46, 58, 62, 73, 110, 120, 139, 186
motivation, 170
MRI, 16, 158, 159, 179
mRNA, 13, 61, 70
murine aorta, xi, 155, 159, 160
mutation(s), 2, 3, 7, 10, 20, 21, 164
myocardial infarction, 14, 15, 26, 84, 85
myocardium, 116
myofibroblasts, 66, 67, 69
N
National Health Service, 142, 146, 147, 151
neovascularization, viii, 57, 60, 66, 67, 68
nephrolithiasis, 84, 85
Netherlands, 5, 15, 119
neural network(s), xi, 169, 171, 173, 174, 175, 177,
179
neurons, 173
neutral, 87
neutrophils, viii, 57, 63, 66, 67, 70
New England, 132
New Zealand, 4, 5, 13, 15, 28
NHS, 142, 146
nitric oxide, viii, 57, 61, 69, 71, 79, 153, 164
nitric oxide synthase, viii, 57, 61, 69, 71, 153, 164
nitrite, 79
nitrogen, 71, 79
nitrogen dioxide, 79
nitrous oxide, 148
nodes, 157, 173
nodules, 179
non-pharmacological treatments, 148
North America, 73, 146, 190
Northern Ireland, 5, 29
null hypothesis, 9
O
obstruction, 190
occlusion, 123, 189
Office of the Inspector General, 151
opportunities, 18, 65
organ(s), 63, 170, 182, 186
osteoarthritis, 21
outcome relationship, 50, 75
overlap, 20, 126, 186
oxidative damage, 71
oxidative stress, 10, 58, 61, 71, 75, 156
oxygen, viii, 57, 61, 74
P
p53, 17, 18, 26, 61
pain, 62
parallel, 82, 129
parallelism, 156
parents, 9
participants, 6, 146
pathogenesis, vii, ix, 2, 10, 12, 17, 19, 20, 58, 61, 62,
73, 74, 75, 78, 114, 162, 182
pathology, 70, 72, 162
pathophysiological, viii, 57, 60, 117, 156, 160
pathophysiology, xi, 10, 64, 72, 148, 149, 152, 155,
156
pathways, 3, 12, 24, 26, 65, 171
PCR, 10
penetrance, 8
peptidase, 9
peptide(s), 34, 61, 75, 158
https://t.me/med1917
Index
200
perfusion, xii, 44, 63, 129, 181, 186
pericardium, 48
perinatal, 164
peripheral vascular disease, 147, 153
peritoneum, 65
permeability, 148
permit, 177
peroxynitrite, 79
PET, 50
pharmacological treatment, 18
phenotype(s), 3, 7, 11, 14, 17, 21, 25, 27, 65
phosphate, 65
physicians, 18, 32, 33, 46, 121, 145, 146, 148, 177,
178
physics, 83, 190
physiology, 72, 162
pilot study, 141
pipeline, 172
placebo, 21
plaque, 40, 42, 59, 74, 159, 166
plasma membrane, vii, 1
plasminogen, 23, 165
platelets, 39, 185
policy, 182
polymer, 43
polymorphism(s), vii, 1, 10, 12, 13, 16, 25, 26
pools, 14
population, viii, 6, 13, 14, 21, 25, 28, 29, 36, 37, 39,
47, 52, 57, 58, 61, 73, 74, 120, 131, 141, 142,
143, 144, 145, 146, 152, 153
porosity, 45, 125, 126
positron, 52
potential benefits, 64
predictability, 34, 49
preservation, 128, 138
prevalence rate, 6
prevention, viii, 2
principles, 60, 88, 94, 95, 101, 103
probability, 6, 171, 172, 173
probability density function, 172
progenitor cells, 154
progesterone, 10
prognosis, 179
pro-inflammatory, 17, 61, 63
proliferation, 14, 15, 17, 109
promoter, 10, 13, 25
propranolol, 76
prosthesis(es), xi, 132, 169, 170, 178
protection, 27, 77, 148, 164
proteins, 3, 10, 11, 13, 34, 40
proteoglycans, 13
proteolysis, 8, 60, 154
proteolytic enzyme, 63
proteomics, 152
pulmonary embolism, 15
P-value, 11, 14
pyelonephritis, 84, 85
pyloric stenosis, 84, 85
Q
quality of life, 151
quantification, 53, 165
quantization, 173
questionnaire, 4
R
race, 22, 58
radiologists, xi, 169, 171, 172
RANTES, 61
reactions, 61
reactive oxygen, viii, 12, 57, 58
receptors, 3, 10, 15, 157
recognition, 72
recombination, 9, 164
reconstruction, 83, 84, 121, 132, 187
recovery, 44, 45, 170
red blood cells, 40
registry(ies), x, 4, 22, 120, 129, 132
reintervention rate, x, 119
relatives, 4, 5, 6, 8, 9, 19, 29, 59, 73
relevance, 12
renal failure, 84, 85
renin, 12, 13, 63, 164
repair, vii, viii, x, 8, 17, 19, 29, 31, 32, 33, 34, 44,
46, 47, 48, 50, 51, 52, 53, 54, 56, 58, 61, 62, 63,
65, 73, 75, 76, 77, 78, 114, 115, 116, 119, 120,
125, 126, 128, 131, 132, 133, 134, 135, 136, 137,
138, 140, 145, 148, 149, 150, 154, 170, 178, 186,
190,191
replication, 15, 27
repressor, 20
requirements, 72, 122
RES, 66, 67
researchers, 32, 72, 110, 157
reserves, 129
resistance, 46, 78, 158
resolution, 159, 171, 172
resources, 72, 145
response, viii, 17, 27, 36, 44, 57, 61, 68, 70, 145, 156
rheology, 79
rights, 12
risk(s), vii, viii, ix, x, 1, 2, 4, 6, 7, 8, 9, 12, 14, 15,
16, 18, 19, 21, 22, 23, 26, 27, 28, 29, 31, 32, 33,
34, 35, 36, 38, 40, 41, 42, 44, 46, 47, 48, 49, 50,
51, 53, 56, 58, 59, 62, 63, 64, 73, 81, 82, 83, 109,
https://t.me/med1917
Index
201
110, 111, 112, 113, 114, 115, 116, 119, 122, 123,
125,127, 128, 129, 131, 134, 135, 136, 140, 144,
145, 146, 147, 148, 149, 150, 152, 153, 156, 162,
170, 186, 189, 190
risk assessment, vii, viii, ix, 31, 42, 47, 49, 81, 82,
83, 116
risk factors, vii, 2, 7, 12, 14, 15, 16, 17, 19, 21, 22,
23, 33, 42, 46, 58, 59, 134, 140, 144, 147, 148,
149, 150, 153, 156
risk profile, 22
RNA, 13, 17, 20, 27
RNA splicing, 17, 20
rodents, 64
ROI, xi, 169
room temperature, 65, 87
root, 183, 185
rubber, 35, 110
rupture-risk, viii, 31, 32, 40, 42, 47, 50, 115
rural areas, 18
S
safety, 131
sample mean, 174
saturation, 173
savings, 147
scaling, 166
scaling law, 159
scar tissue, 111
scarcity, 65
science, 166
sclerosis, 178
scope, 148
screening data, x, 139, 140
secretion, viii, 8, 57, 63, 70, 74, 113
segregation, 8
senescence, 17
sensitivity, xi, 34, 62, 140, 169
sequencing, vii, 2, 10, 17
Serbia, 81
serum, 12, 34, 63, 76, 148, 152
sex, 2, 6, 8, 9, 13, 23, 34, 36, 59, 73
sham, viii, 57
shape, 41, 42, 53, 122, 127, 156
shear, 39, 41, 42, 43, 44, 48, 59, 71, 73, 79, 156, 157,
158, 159, 160, 161, 162, 166
showing, 121
sibling(s) 2, 6, 9, 23, 28, 29, 73
signaling pathway, 13
signalling, 27
significance level, 15
signs, 17
silver, 86, 87
simulation(s), viii, xi, 31, 39, 43, 45, 46, 48, 49, 51,
53, 56, 157, 159, 160, 161, 163, 167, 182, 187,
188, 190
skin, 65
smoke exposure, 6
smoking, 2, 6, 7, 15, 17, 22, 27, 42, 58, 73, 143, 147,
156
smoking cessation, 59
smooth muscle, vii, 1, 3, 10, 12, 15, 17, 20, 21, 36,
40, 44, 58, 60, 65, 74, 75, 111, 112, 113, 156, 162
smooth muscle cells, 10, 15, 17, 40, 58, 60, 65, 74,
111, 112, 113, 156, 162
SNP, 11, 12, 13, 14, 15, 17
society, 131, 153, 179
software, 38, 47, 183
solution, viii, 31, 44, 65, 87, 145
Spain, 149, 169
specialists, 33, 46, 172
species, viii, 12, 57, 58, 61, 74
speculation, 38
spinal cord injury, 156, 163
spleen, 85
stability, ix, 74, 81, 112
stabilization, 64
stabilizers, 64
stagnation, xii, 181, 185
standard deviation, 174, 175, 176, 177
standard error, 88
state, 32, 36, 43, 70, 122
statin, 23, 63, 77
statistics, 19, 73, 171, 179
stem cells, 154
stenosis, viii, 57, 65, 123
stent, 75, 115, 121, 123, 127, 129, 131, 135, 170,
172, 182, 186, 190
stent-graft, viii, x, 31, 32, 44, 45, 46, 51, 78, 116,
120, 125, 126, 128, 133, 134, 136, 137, 138, 187,
188, 189, 191
stimulation, 61
stratification, 16, 18
stress, viii, 8, 23, 31, 34, 35, 36, 37, 38, 39, 40, 41,
42, 43, 44, 45, 47, 48, 49, 50, 51, 52, 53, 54, 55,
56, 59, 60, 61, 71, 73, 79, 82, 111, 115, 116, 117,
152, 156, 157, 158, 159, 160, 161, 162, 166, 182,
187, 188, 189
stretching, 188
stroke, 11, 14, 15, 19
structural changes, vii, 83, 109, 111
structural characteristics, ix, 81, 83
structural protein, 71
structure, viii, ix, 10, 31, 38, 39, 41, 43, 44, 45, 48,
51, 52, 53, 55, 56, 58, 60, 61, 82, 83, 87, 107,
https://t.me/med1917
Index
202
109, 110, 111, 112, 113, 114, 116, 163, 173, 183,
186, 187, 188, 190
suppression, 63
surrogates, 137
surveillance, 21, 23, 33, 35, 45, 51, 52, 54, 73, 75,
77, 116, 126, 135, 150, 151, 153, 170
survival, vii, x, 1, 15, 33, 58, 119
survival rate, x, 58, 119
susceptibility, vii, 1, 9, 23, 24, 25, 26, 158
suture, 189
Sweden, 4, 5, 6, 142, 146
symptoms, viii, 31, 47, 52, 62, 156
syndrome, 3, 16, 19, 20, 21
synergistic effect, 111
synthesis, 12, 20, 24, 60, 152
systolic blood pressure, 60
systolic pressure, 35
T
T lymphocytes, 66, 67
target, viii, 31, 128, 174, 190
target population, viii, 31
Task Force, 19, 75, 143, 150
teams, 34
technical assistance, 114
techniques, viii, 2, 4, 10, 31, 32, 36, 44, 48, 74, 87,
115, 128, 129, 131, 134, 157, 161, 171
technological advances, 131
technology, 161, 186
tensile strength, 54, 60
tension, 60
test data, 37
testing, 8, 9, 16, 18, 35, 85, 88, 171, 173, 175, 176,
177
texture, xi, 169, 170, 171, 172, 173, 174, 175, 176,
177, 178, 179
TGF, 20, 25, 156, 158
theatre, 125
therapeutic targets, 64
therapy, xi, 62, 63, 133, 135, 136, 137, 138, 148,
149, 154, 169
thinning, 18, 38
thoracoabdominal, xi, 181, 182, 190
three-dimensional model, 48
threshold level, 62
thrombocyte, 42
thromboembolism, xii, 24, 181, 182, 185
thrombosis, 78, 79, 120, 127
thrombus, ix, xi, 32, 38, 40, 42, 47, 48, 49, 50, 51,
52, 54, 55, 63, 64, 77, 82, 83, 103, 105, 107, 109,
110, 113, 114, 115, 117, 121, 122, 134, 163, 169,
170, 172, 177, 182
thyroid, 85
TIMP-1, viii, 57, 60, 63, 66, 69, 70, 71, 113
tissue, viii, 10, 13, 16, 35, 36, 37, 40, 43, 44, 51, 57,
60, 61, 62, 63, 64, 65, 70, 71, 72, 83, 87, 111,
114, 115, 152, 157, 164, 165, 179, 189
TNF-alpha, 61
tobacco smoke, 7
trainees, 48
training, 46, 148, 154, 171, 173, 174, 175, 176, 177
traits, 8, 15, 23
transcription, 17
transduction, 162
transformation, 60
transforming growth factor, 3, 11, 114, 162
trauma, 62, 65
treatment, x, xi, 27, 32, 33, 62, 64, 65, 73, 74, 75, 77,
78, 110, 119, 120, 127, 129, 131, 134, 135, 147,
148, 153, 154, 169, 170, 171, 177, 178, 182, 186,
187, 190, 191
trial, x, 21, 33, 46, 47, 50, 52, 54, 62, 64, 119, 132,
141, 142, 143, 145, 146, 147, 149, 150, 151, 154,
173
tumor(s), 27, 61, 79, 84, 85
tumor necrosis factor, 61
turbulence, 58
turbulent, viii, 57, 60, 65, 70, 71
turnover, 44, 70, 157
twins, 6
type 2 diabetes, 14, 27
tyrosine, 71
U
ultrasonography, x, 18, 120, 139, 140, 143, 149
ultrasound, xi, 5, 7, 16, 28, 33, 36, 54, 62, 110, 140,
141, 145, 147, 150, 155, 158, 159, 160, 165, 166
uniaxial tension, 35, 36
uniform, 35, 41, 43, 111, 114, 186, 187
United Kingdom (UK), 4, 5, 13, 15, 33, 46, 116, 140,
141, 153
United States (USA), 2, 4, 5, 6, 14, 33, 47, 48, 58,
139, 143, 145, 147, 182
updating, 53, 163
urine, 166
V
validation, xi, 15, 22, 64, 71, 169, 175, 176, 177
variables, 44, 115
variations, ix, 4, 13, 36, 82, 110
vascular diseases, 15, 143
vascular surgeon, 33, 48, 121, 143, 146
vascular surgery, 72, 73, 131, 135, 136, 137, 153,
190
https://t.me/med1917
Index
203
vascular wall, ix, 27, 60, 63, 71, 82, 90, 112, 115,
164
vascularization, 69
vasculature, 59, 74, 152
VCAM, 159
vector, xi, 169, 173, 174, 175, 177, 179, 183, 185
vein, 17
velocity, 60, 160, 183, 184, 185, 188
vessels, x, 46, 111, 120, 125, 128, 138, 183
viscera, 182, 186
viscoelastic properties, 39
viscosity, 183
vulnerability, 17, 27, 79, 152
W
weakness, 65
Western Australia, 140, 141, 143
western blot, 69, 70
workers, 18
worldwide, 124, 125
Y
yield, xi, 35, 139, 140, 145, 147, 148, 149
https://t.me/med1917
Соседние файлы в папке Библиотека им академика М.И. Перельмана